Cleared Traditional

Stella (K221752) - FDA 510(k) Clearance

Class II Dental device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221752 · Shinhung Mst Co., Ltd. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
353d
Days
Class 2
Risk

K221752 is an FDA 510(k) clearance for the Stella. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by Shinhung Mst Co., Ltd. (Wonju-Si, KR). The FDA issued a Cleared decision on June 4, 2023 after a review of 353 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Shinhung Mst Co., Ltd. devices

Submission Details

510(k) Number K221752 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 16, 2022
Decision Date June 04, 2023
Days to Decision 353 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
226d slower than avg
Panel avg: 127d · This submission: 353d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 304
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K221752.
Straumann SLActive labeling changes
K223083 · Institut Straumann AG · Jun 2023
IR SLA Type Implant System
K222144 · Biotem Co., Ltd. · Jun 2023
SNUCONE Tissue Level Implant System
K222792 · Snucone Co., Ltd. · Jun 2023
Genesis ACTIVE Implant System
K223814 · Keystone Dental, Inc. · May 2023
Point implant system
K222738 · Pointnix Co., Ltd. · Apr 2023
Provata Implant System
K222457 · Southern Implants (Pty), Ltd. · Mar 2023